Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors.
Written by Pamela Kock for The Motley Fool -> 12,000 shares were exercised from options and sold for a total of ~$673,000 on May 12, 2026. All shares were transacted directly via option exercise and immediate sale; no indirect entities or gifts were involved. Johannessen retai
12,000 shares were exercised from options and sold for a total of ~$673,000 on May 12, 2026.
All shares were transacted directly via option exercise and immediate sale; no indirect entities or gifts were involved.
Johannessen retains 17,754 Common Stock shares, maintaining a continuing economic interest in the company.
Jan Johannessen, Director at Twist Bioscience Corporation (NASDAQ:TWST) , reported the exercise and immediate sale of 12,000 shares of Common Stock for a transaction value of approximately $673,000 according to the SEC Form 4 filing .
Transaction value based on SEC Form 4 weighted average purchase price ($56.12); post-transaction value based on May 12, 2026 market close ($993,336.30).
* 1-year price change calculated using May 12th, 2026 as the reference date.
Twist Bioscience Corporation is a leading provider of synthetic DNA and related products, leveraging proprietary silicon-based DNA synthesis technology to address the needs of the healthcare and life sciences sectors. The company’s scalable platform enables efficient production of high-quality DNA, supporting applications in drug discovery, diagnostics, and data storage. Strategic collaborations and a diversified product portfolio position Twist Bioscience to capitalize on growth in synthetic biology and genomics-driven research.
Jan Johannessen, a director at Twist Bioscience, sold 12,000 shares of the company’s stock for a total of $673,440. But he exercised stock options, received as part of his compensation, for the same number of shares at $14 per share. That was well below its price on the day of the transaction, which was $56.12 per share. This represents a hefty profit, and that’s exactly what stock options are intended to do.
